Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants

By Zhang Guang-Yi   Zhang Quan-Guang  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1373-1383

Informa Healthcare

Access to resources Recommend Favorite

Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration

By Westerlund Nina   Zdrojewska Justyna   Courtney Michael J   Coffey Eleanor T  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase

By Palin K.   McCusker R.   Strle K.   Moos F.   Dantzer R.   Kelley K.  

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 629-635

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of c-jun-N-Terminal Kinase (JNK)

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 755-766

Bentham Science Publishers

Access to resources Recommend Favorite

Immunosuppressant rapamycin inhibits protein kinase C and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis

By Oh C.-D.   Kim S.-J.   Ju J.-W.   Song W.K.   Kim J.-H.   Yoo Y.J.   Chun J.-S.  

European Journal of Pharmacology, Vol. 427, Iss. 3, 2001-09 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite